We went on to investigate the therapeutic potential of eEF2K inhibition for DS‐associated cognitive impairments and synaptic failure by using two structurally distinct small molecules eEF2K inhibitor: A‐484594 (AG) and NH125.26, 47. This evidence concerns the gene EEF2K and Cognitive impairment.